Mangalore, India – [13. 03. 2025] – BEBIG Medical’s advanced SagiNova brachytherapy system is now operational at Father Muller Medical College Hospital (FMMCH), enhancing the newly inaugurated healthcare facilities. This milestone coincides with Father Muller Charitable Institutions (FMCI) celebrating the 184^th Birth Anniversary of its Founder, honoring a century-long legacy of compassionate medical service.

The SagiNova system positions FMMCH at the forefront of accessible cancer care, delivering precise, high-dose radiation therapy to patients at reduced costs. As a global innovator in brachytherapy, BEBIG Medical continues to partner with hospitals worldwide to democratize cutting-edge oncology solutions. The launch aligns with FMCI’s mission to integrate modern technology with its founding values of empathy and equity. By adopting SagiNova, FMMCH strengthens its oncology services, offering advanced treatment options to underserved communities.

About BEBIG Medical

BEBIG Medical GmbH is a global provider of radiation therapy products dedicated to cancer treatment with 40 years’ experience in the field and a track record of proven clinical outcomes through robust and innovative technology. 

Specializing in the research and development, manufacturing, and worldwide distribution of radiation therapy medical devices, BEBIG Medical provides comprehensive product portfolio with linear accelerator, high-dose-rate brachytherapy, X-ray therapy products, and intraoperative radiation therapy devices. BEBIG Medical boasts a substantial presence with over 700 active installation bases across more than 80 countries and regions, facilitated by a network of over 70 global distributors. 

With strategically positioned offices and a team of seasoned professionals in Europe, United States, and Asia, the company aims to deliver affordable healthcare solutions to everyone in the world. 

More information, please visit www.bebigmedical.com